X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

Cleanroom Technology Market Growth to 2019 Driven by APAC and Latin America

Yuvraj_pawp by Yuvraj_pawp
7th September 2014
in Market Moves

Cleanroom Technology Market by Equipment (HVAC System, HEPA Filter, Air Shower, Air Diffuser), Consumables (Apparel, Gloves, Wipes, Disinfectants), Construction (Hardwall, Softwall), & by End User (Pharmaceutical, Biotech) – Global Forecast to 2019 is a new, September 2014 research report of 190 pages, now available with ReportsnReports.com at http://www.reportsnreports.com/reports/297420-cleanroom-technology-market-by-equipment-hvac-system-hepa-filter-air-shower-air-diffuser-consumables-apparel-gloves-wipes-disinfectants-construction-hardwall-softwall-by-end-user-pharmaceutical-biotech-global-forecast-to-2019.html . Over the past few years, the cleanroom technology market has witnessed a stable growth. The market is expected to grow at a CAGR of 5.5% from 2014 to 2019 to reach $3,761.9 million by 2019.

 

The overall growth in the cleanroom technology market is largely driven by rising regulatory concerns regarding quality of products and safety of working personnel; an upsurge in development of new biologics, increasing demand of sterilized pharmaceutical formulations, and rising requirement of cleanrooms for various applications in medical device industry. However, the high cost associated with the establishment and use of cleanrooms may restrict the growth of the market to a certain extent.

 

During the forecast period the cleanroom gloves, wipes, and hardwall cleanrooms continue to drive and dominate the healthcare cleanrooms market. A majority share of this growth can be attributed to widening applications of cleanroom consumables and modular cleanrooms. The several advantages such as flexibility in construction and cost effectiveness would increase the demand for hardwall cleanrooms. The development of new product developments in the gloves and wipes would help to enhance the growth of these segments during the forecast period of 2014-2019.

 

By 2019, North America will continue to dominate the healthcare cleanrooms market, followed by Europe, Asia-Pacific and Rest of the world. However, the market share of the North American region will decrease during 2014 to 2019, primarily due to the increase in demand for cleanrooms in the Asia-Pacific and Latin American countries. Majority of the growth in these regions is primarily driven by the increasing development of healthcare industry in China, India, and Brazil.

 

Companies profiled in this global cleanroom technology market 2014 – 2019 research report include Azbil Corporation, Taikisha Ltd., Kimberly-Clark Corporation, Illinois Tool Works Inc., Royal Imtech N.V., E.I. Du Pont De Nemours And Company, Ardmac Ltd., Alpiq Group, Clean Air Products and M+W Group. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=297420 .

 

This cleanroom technology market report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

 

The report provides insights on the following pointers:

 

Market Penetration: Comprehensive information on product portfolios offered by the top players in the cleanroom technology market. The report analyzes the healthcare cleanrooms market by technology, by construction, and by end user across all geographies

Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the cleanroom technology market

Market Development: Comprehensive information about the lucrative emerging markets by technology, construction, end user and geography

Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the cleanroom technology market

Competitive Assessment: In-depth assessment of market positions, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the cleanroom technology market
Other newly published medical devices market research reports available with ReportsnReports.com include:

 

Patient Handling Equipment Market by Product (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory), Type of Care (Bariatric, Fall, Critical, Wound), Accessories (Lifting, Transfer) & by End User (Home Care, Hospital) – Global Forecast to 2019 is a 150 page research report that says government support for safe patient handling has boosted the growth of the patient handling equipment market. The medical beds segment will have the largest share of the total patient handling equipment market in 2014 and will continue to grow with a healthy CAGR in the forecast period. Getinge Group was the clear market leader in patient handling equipment market in 2014.Getinge Group also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Hill-Rom distantly followed Getinge Group and thus became the second leading company in the patient handling equipment market in 2014. Stryker will be the third leading company in 2014 in patient handling equipment market. Companies like Stryker Corporation, Hill-Rom Holdings Inc., Invacare Corporation, Prism Medical, Getinge Group (Arjohuntleigh), Guldmann Inc., Linet Spol. S.R.O., Stiegelmeyer & Co. GMBH, Handicare and Joerns Healthcare are profiled in this report available at http://www.reportsnreports.com/reports/297347-patient-handling-equipment-market-by-product-wheelchair-scooter-beds-bathroom-safety-mechanical-ambulatory-type-of-care-bariatric-fall-critical-wound-accessories-lifting-transfer-by-end-user-home-care-hospital-global-forecast-to-2019.html .

 

Freeze Drying / Lyophilization Equipment Market by Scale (Lab, Pilot, & Industrial), Technology (Rotary, Manifold, & Tray – style), Accessories (Loading/Unloading System, Vacuum System, Clean-in-Place System, Control System) – Global Forecast to 2019 research report says the industry is expected to grow at a high CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,655.9 million by 2019. By 2019, Asia-Pacific will continue to dominate and drive the freeze drying equipment market, primarily due to the increasing demand for lyophilization in pharmaceutical and biotech industries. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotech industries in China and India. The global freeze drying equipment market is fragmented in nature with the presence of many small and big firms. The major players in the freeze drying market include Tofflon Science and Technology Co., Ltd.(China), IMA S.p.A.(Italy), GEA Group (Germany), Azbil Corporation (Japan), SP Industries Inc. (U.S.), Labconco Corporation (U.S.), Optima Packaging Group GmbH (Germany), HOF Enterprise Group (Germany), Martin Christ Gefriertrocknungsanlagen GmbH (Germany), and Millrock technology, Inc. (U.S.). Complete report is available at http://www.reportsnreports.com/reports/297419-freeze-drying-lyophilization-equipment-market-by-scale-lab-pilot-industrial-technology-rotary-manifold-tray-style-accessories-loading-unloading-system-vacuum-system-clean-in-place-system-control-system-global-forecast-to-2019.html .

 

About Us:

 

ReportsnReports.com is an online market research reports library of 450,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

SOURCE ReportsnReports

Previous Post

Prolor Biotech R&D Facility, Weizmann Science Park, Israel

Next Post

Raleigh awards economic development incentive to Xellia Pharmaceuticals

Related Posts

Regeneron, Intellia to develop CRISPR/Cas9-based treatments
Market Moves

Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform

29th January 2022
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Indian Pharma Industry To Grow By 9-11% In FY22- ICRA

7th January 2022
Market Moves

IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance

26th October 2021
My Personal Therapeutics and Pentavere receive EUREKA AI Therapeutics Funding to support the development of My Personal Therapeutics - digital therapeutics for Lung Cancer
Manufacturing

Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute

2nd August 2021
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Biopharma Market to grow at 10.6% CAGR between 2020 and 2027

3rd December 2020
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Antares Vision acquires pharma packaging leak specialist for $17.9m

20th July 2020
Next Post

Raleigh awards economic development incentive to Xellia Pharmaceuticals

Latest News

NIH begins study of allergic reactions to Covid-19 vaccines
News

To Treat COVID WHO Approves Monoclonal Antibody Tocilizumab

18th February 2022
Envirotainer introduces the RAP for the future - part of the Releye series
Packaging & Logistic

Envirotainer introduces the RAP for the future – part of the Releye series

14th February 2022
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
Packaging & Logistic

Opticooler receives technical approval by Japanese major airlines

14th February 2022
Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease
Press Statements

Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease

14th February 2022
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In